NANOBIOTIX (NANO.PA) Stock Income Statement
Europe - EPA:NANO - FR0011341205 - Common Stock
15.47 EUR
-0.01 (-0.06%)
| TTM (2025-6-30) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 7.16M | -11.61M | 30.06M | 0.00 | 10.00K | |||
| Operating Expenses | 51.09M | 56.78M | 56.84M | 46.70M | 52.59M | |||
| Research and Development | 32.01M | 39.39M | 37.10M | 31.28M | 29.17M | |||
| Selling, General, and Administrative Expenses | 20.92M | 20.06M | 21.66M | 17.48M | 19.02M | |||
| Operating Income | -43.93M | -68.39M | -26.78M | -46.70M | -52.58M | |||
| Interest Income/Expense | -8.89M | -2.47M | -13.09M | -3.48M | 5.57M | |||
| Other Income/Expense | N/A | 1.00K | 1.00K | 1.00K | 13.00K | |||
| Non Recurring Items | 1.15M | 2.83M | 285.00K | -6.86M | N/A | |||
| Income Before Taxes | -51.68M | -68.03M | -39.58M | -57.03M | -47.00M | |||
| Income Tax | -37.00K | 101.00K | 120.00K | 10.00K | 5.00K | |||
| Net Income | -51.64M | -68.13M | -39.70M | -57.04M | -47.00M | |||
| EBITDA | -42.30M | -66.77M | -25.27M | -45.20M | -51.02M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -1.09 | -1.44 | -1.08 | -1.64 | -1.35 | |||
| Non GAAP EPS | -1.09 | -1.44 | -1.08 | N/A | -1.35 | |||
| Statistics | ||||||||
| Profit Margin | -721.67% | 586.89% | -132.08% | N/A | -470030.00% | |||
| Operating Profit Margin | -613.92% | 589.13% | -89.09% | N/A | -525790.00% | |||
All data in EUR